Search

Context Monocarboxylate transporter 8 (MCT8) deficiency is a rare genetic disease that leads to severe global developmental delay. MCT8 facilitates thyroid hormone (TH) transport across the cell membrane, and the serum TH profile is characterized by high T3 and low T4 levels. Recent studies have shown that the chemical chaperone sodium phenylbutyrate (NaPB) restored mutant MCT8 function and increased TH content in patient-derived induced pluripotent stem cells, making it a potential treatment for MCT8 deficiency. Objective We aimed to assess the efficacy and safety of glycerol phenylbutyrate (GPB) in MCT8 deficiency. Methods We treated 2 monozygotic twins aged 14.5 years with MCT8 deficiency due to P321L mutation with escalating doses of GPB over 13 months. We recorded TH, vital signs, anthropometric measurements, and neurocognitive functions. Resting metabolic rate (RMR) was measured by indirect calorimetry. Serum metabolites of GPB were monitored as a safety measure. In vitro effects of NaPB were evaluated in MDCK1 cells stably expressing the MCT8P321L mutation. The effects of GPB were compared to the effects of DITPA and TRIAC, thyromimetic medications that the patients had received in the past. Results NaPB restored mutant MCT8 expression in MDCK1 cells and increased T3 transport into cells carrying the P321L mutation. GPB treatment reduced high T3 and increased low T4 levels. The patients showed a significant weight gain simultaneously with a reduction in RMR. Only minor neurocognitive improvement was observed, in hyperreflexia score and in cognitive functions. Serum metabolites did not exceed the toxic range, but elevated liver transaminases were observed. Conclusion In the first report of GPB treatment in MCT8 deficiency we found an improvement in TH profile and body mass index, with minor neurodevelopmental changes. [ABSTRACT FROM AUTHOR]

BACKGROUND Integrase strand transfer inhibitors (INSTIs) are a commonly used antiretroviral therapy (ART) class in people with human immunodeficiency virus (HIV) and associated with weight gain. We studied the association of INSTI-based ART with systolic and diastolic blood pressure (SBP and DBP). METHODS We recruited 50 people taking INSTI-based ART and 40 people taking non-INSTI-based ART with HIV and hypertension from the University of Alabama at Birmingham HIV clinic. Office BP was measured unattended using an automated (AOBP) device. Awake, asleep, and 24-hour BP were measured through ambulatory BP monitoring. Among participants with SBP ≥130 mm Hg or DBP ≥80 mm Hg on AOBP, sustained hypertension was defined as awake SBP ≥130 mm Hg or DBP ≥80 mm Hg. RESULTS Mean SBP and DBP were higher among participants taking INSTI- vs. non-INSTI-based ART (AOBP-SBP/DBP: 144.7/83.8 vs. 135.3/79.3 mm Hg; awake-SBP/DBP: 143.2/80.9 vs. 133.4/76.3 mm Hg; asleep-SBP/DBP: 133.3/72.9 vs. 120.3/65.4 mm Hg; 24-hour-SBP/DBP: 140.4/78.7 vs. 130.0/73.7 mm Hg). After multivariable adjustment, AOBP, awake, asleep, and 24-hour SBP were 12.5 (95% confidence interval [CI] 5.0–20.1), 9.8 (95% CI 3.6–16.0), 10.4 (95% CI 2.0–18.9), and 9.8 (95% CI 4.2–15.4) mm Hg higher among those taking INSTI- vs. non-INSTI-based ART, respectively. AOBP, awake, asleep, and 24-hour DBP were 7.5 (95% CI 0.3–14.6), 6.1 (95% CI 0.3–11.8), 7.5 (95% CI 1.4–13.6), and 6.1 (95% CI 0.9–11.3) mm Hg higher among those taking INSTI- vs. non-INSTI-based ART after multivariable adjustment. All participants had SBP ≥130 mm Hg or DBP ≥80 mm Hg on AOBP and 97.9% and 65.7% of participants taking INSTI- and non-INSTI-based ART had sustained hypertension, respectively. CONCLUSIONS INSTI-based ART was associated with higher SBP and DBP than non-INSTI-based ART. [ABSTRACT FROM AUTHOR]

Objective: Obesity is a chronic disease that affects more than 400 million adults with severe comorbidities. The search for new treatments to reduce its negative consequences is necessary. Orexins are hypothalamic neuropeptides involved in various physiological processes related to obesity. The aim of this study was to investigate the consequences of chronic orexin‐A treatment in mouse models. Methods: Female wild‐type C57BL/6 mice that were obesity‐prone or obesity‐resistant and mice that were deficient for orexin receptors were fed with a high‐fat diet. Glucose tolerance, indirect calorimetry, expression of brain neuropeptides and receptors, microglial activation, and microbiota were determined to evaluate the role of orexins on metabolic flexibility. Results: Orexin‐A reduces weight gain in obesity‐prone mice. This reduction is associated with a decrease in body fat, food intake, steatosis, and insulin resistance, as well as alterations of intestinal microbiota composition. A decreased expression of orexin receptors and neuropeptides involved in food intake was also observed in the hypothalamus. Conclusions: Our data support the notion that orexin receptor signaling is involved in different aspects of energy metabolism and can mitigate several dysfunctions associated with obesity, suggesting that orexin receptors can represent new targets for obesity treatment. [ABSTRACT FROM AUTHOR]

Objective: The objective of this study was to determine the preliminary effectiveness of an intervention to mitigate adverse pregnancy outcomes associated with pre‐pregnancy obesity in American Samoa. Methods: We enrolled n = 80 low‐risk pregnant women at <14 weeks' gestation. A complete case analysis was conducted with randomized group assignment (group prenatal care‐delivered intervention vs. one‐on‐one usual care) as the independent variable. Primary outcomes were gestational weight gain and postpartum weight change. Secondary outcomes included gestational diabetes screening and exclusive breastfeeding at 6 weeks post partum. Other outcomes reported include gestational diabetes incidence, preterm birth, mode of birth, infant birth weight, and macrosomia. Results: Gestational weight gain was lower among group versus usual care participants (mean [SD], 9.46 [7.24] kg vs. 14.40 [8.23] kg; p = 0.10); postpartum weight change did not differ between groups. Although the proportion of women who received adequate gestational diabetes screening (78.4% group; 65.6% usual care) was similar, there were clinically important between‐group differences in exclusive breastfeeding (44.4% group; 25% usual care), incidence of gestational diabetes (27.3% group; 40.0% usual care), and macrosomia (8.3% group; 29.0% usual care). Conclusions: It may be possible to address multiple risk factors related to intergenerational transmission of obesity in this high‐risk setting using a group care‐delivered intervention. [ABSTRACT FROM AUTHOR]

Purpose: Weight gain after breast cancer poses health risks. We aimed to identify factors associated with weight gain during adjuvant endocrine therapy (AET). Methods: Women initiating AET enrolled in a prospective cohort. Participants completed FACT-ES plus PROMIS pain interference, depression, anxiety, fatigue, sleep disturbance and physical function measures at baseline, 3, 6, 12, 24, 36, 48 and 60 months. Treatment-emergent symptoms were defined as changes in scores in the direction indicative of worsening symptoms that exceeded the minimal important difference at 3 and/or 6 months compared to baseline. We used logistic regression to evaluate associations of clinicodemographic features and treatment-emergent symptoms with clinically significant weight gain over 60 months (defined as ≥ 5% compared to baseline) in pre- and post-menopausal participants. Results: Of 309 participants, 99 (32%) were pre-menopausal. The 60 months cumulative incidence of clinically significant weight gain was greater in pre- than post-menopausal participants (67% vs 43%, p < 0.001). Among pre-menopausal participants, treatment-emergent pain interference (OR 2.49), aromatase inhibitor receipt (OR 2.8), mastectomy, (OR 2.06) and White race (OR 7.13) were associated with weight gain. Among post-menopausal participants, treatment-emergent endocrine symptoms (OR 2.86), higher stage (OR 2.25) and White race (OR 2.29) were associated with weight gain while treatment-emergent physical function decline (OR 0.30) was associated with lower likelihood of weight gain. Conclusions: Weight gain during AET is common, especially for pre-menopausal women. Clinicodemographic features and early treatment-emergent symptoms may identify at risk individuals. Implications for cancer survivors: Patients at risk for weight gain can be identified early during AET. Clinical trials.gov identifier: NCT01937052, registered September 3, 2013. [ABSTRACT FROM AUTHOR]

This study investigates the influence of saline environments, including conditions arising in the vicinity of roads with winter maintenance by de-icing salts, and exposure in other specific environments affected by chloride ion deposition, on the material properties of EOS PA2200 (PA12). The research focuses on assessing weight gain and mechanical properties using tensile testing. The experimental findings provide insights into the potential effects of saline environments on the performance and durability of PA2200, contributing to a better understanding of its suitability for marine applications. The results reveal significant variations in weight gain and mechanical properties under different exposure durations and concentrations of saline solution. Additionally, microscopic analysis offers valuable insights into the morphological changes occurring within the material structure due to saline water exposure. The implications of these findings are discussed in the context of material selection and design considerations for marine engineering applications. This research contributes to the broader understanding of material behavior in corrosive environments, offering valuable guidance for the development of more resilient and durable materials for marine applications. [ABSTRACT FROM AUTHOR]

Introduction: The aim of this study was to investigate changes in echocardiographic right ventricular (RV) indices in relation to the degree of fluid accumulation between hemodialysis sessions, evaluated according to the recommended threshold of interdialytic‐weight‐gain corrected for dry weight (IDWG%). Methods: A post‐hoc analysis was performed using data from 41 maintenance hemodialysis patients. Patients were divided into a higher (>4.5%) and a lower (<4.5%) IDWG% group and underwent an echocardiographic assessment at the start and the end of the 3‐day and the 2‐day interdialytic interval. Results: RV systolic pressure (RVSP) increments were more pronounced in the higher compared to the lower IDWG% group (16.43 ± 5.37 vs. 14.11 ± 13.38 mm Hg respectively, p = 0.015) over the 3‐day interval, while changes in RV filling pressures, did not differ significantly between the groups (p = 0.84). Conclusions: During the 3‐day interdialytic interval, pulmonary circulation is particularly overloaded in patients with fluid accumulation higher than the recommended thresholds, as evidenced by higher RVSP elevations. [ABSTRACT FROM AUTHOR]

Background: Experimental mice are often single-housed either for an individual analysis (feeding behavior, imaging, calorimetry) or as a stress paradigm (social isolation) in translational biomedical research. Reports of the influence of single housing in rodents are conflicting and may depend on age and duration of isolation. Sex is often not included as a factor. In this study we investigated the effects of 4-week single housing in male and female mice on behavior, body weight, and serum corticosterone levels. Results: Behavioral tests showed no effect on anhedonia and stress coping, anxiety and motor exploration. Social avoidance occurred in both males and females. Regarding physiological effects, single housing did not induce changes in serum corticosterone levels, but reduced body weight gain. Conclusions: While some mouse studies of chronic social isolation reported depression-related disturbances, our data suggest that single housing might be not necessarily be too stressful. This is important for animal welfare regulations and experiments in life science research. [ABSTRACT FROM AUTHOR]

1. An experiment was carried out to examine if a heterogeneous diet consisting of pellets and coarse cereal particles would result in a similar feed intake to pelleted-only diets. It also considered whether coarser particles entering the gizzard would encourage the development of the gizzard and thus improve digestive tract functionality. Maize and wheat were hammer milled through a 3 mm screen after coarse grinding using either one of the two screens with a novel pattern. Three pellet-only diets were produced based on three grinding sizes. Additionally, four diets were produced by separating coarse cereal particles from moderately coarse particles by sieving either once or twice, pelleting the remainder and finally mixing these into a complete heterogeneous diet.2. No difference in performance between birds fed the three pelleted-only diets was observed. However, heterogeneous diets resulted in a lower feed intake (FI) and weight gain (WG) than pelleted-only diets (p < 0.05). The dietary treatments neither affected the feed conversion ratio nor ileal digestibility of starch and protein (p > 0.05). As expected, feeding a heterogeneous diets increased (p < 0.05) the relative weight of the gizzard and its contents. Approximately 50% of the particles in the small intestine were between 0.15 mm and 0.36 mm in diameter, with more fine particles observed when the pelleted-only diets containing coarsely ground cereals were fed, confirming the capacity of the gizzard to finely grind feed.3. Sieving of the diet remaining in the feeder during 4 h of feeding two of the heterogeneous diets showed that the particles > 2.8 mm disappeared first (p < 0.05), showing the birds’ preference for larger particles when offered heterogeneous diets. Although the birds were able to handle the coarse microstructure of the diets without any negative effects, the reduced performance in the case of heterogeneous diets might have been related to feed intake issues and particle selection, resulting in an imbalance in nutrient intake. [ABSTRACT FROM AUTHOR]

Background: This research investigated the impact of selenium-nanoparticles (Se-NPs) supplemented in sunflower meal (SM)-based diets on digestibility, mineral absorption, and growth performance of Catla catla. Se-NPs were added to seven test meals in varying amounts (0, 0.5, 1, 1.5, 2, 2.5 and 3 mgkg− 1). A total of 315 fish were evenly allocated three replicate tanks, with 15 fish per tank, and given diets equivalent to (5%) of their wet biomass daily for a period of 90 days. Results: The test diet (T-D) supplemented with 1.5 mgkg− 1 Se-NPs yielded remarkable results, including a significant increase in mean weight gain (14 g), an impressive average weight gain percentage (208%), a 100% survival rate, with no mortality observed and the highest specific growth rate (1.25). Moreover, 1.5 mgkg− 1 Se-NPs (T-D-IV) demonstrated superior nutritional digestibility (CP, 76%; CF, 79% and GE, 74%). Additionally, the diet 1.5 mgkg− 1 Se-NPs showed enhanced mineral absorption (K, P, Ca, Na, Zn, Cu and Fe) than other diets. Conclusion: It was practically proven that the growth indices, nutrient absorption, and mineral status of C. catla were significantly improved by Se-NPs supplemented SM-based diets, with the optimum level of supplementation being 1.5 mgkg− 1. [ABSTRACT FROM AUTHOR]

This study aimed to determine the effects of spray dried plasma (SDP) on growth performance, carcass traits, tibia quality, and hemagglutination inhibition titers in broilers fed two nutritional strategies with high or low nutrient density. In the study, 816 one-day-old Ross 308 male broiler chickens were divided into a 2 × 2 factorial arrangements consisting of four treatment groups with 12 replicates (17 birds/replicate) based on diets with high nutrient density (HND) or low nutrient density (LND) from d 0 to 42 and receiving either control or 1% SDP diets during d 0 to 10. The results showed that feed intake (FI) and body weight gain (BWG) were increased (P < 0.05) and feed conversion ratio (FCR) was significantly reduced (P = 0.003) for broilers fed HND diets from d 0 to 42. The inclusion of SDP increased the BWG (P < 0.001), FI (P < 0.001), and FCR (P < 0.05) during d 0 to 10 of broiler life but not effect of SDP was observed for the whole 0–42 d period. Carcass yield increased with HND (P < 0.001) and dietary SDP (P = 0.002). However, HND feeding significantly decreased liver (P < 0.001), bursa of Fabricius (P = 0.002), abdominal fat (P < 0.001), proventriculus (P < 0.001) and gizzard weight (P < 0.001), but increased heart weight (P = 0.013), although spleen weight remained unaffected (P > 0.05) on d 42. Tibial bone morphometric and mechanical properties improved (P < 0.05) with SDP supplementation, and bone ash, Ca, and P remained unaffected (P > 0.05) on d 14. With the exception at d 28 (P = 0.037), the antibody titer to ND virus was similar among all treatment groups (P > 0.05) at d 0, 14, and 42. In conclusion, HND diets improve performance of broilers during the whole period and SDP supplementation during starter phase improve performance at this period, but also increased carcass yield, and tibial quality. Therefore, inclusion of SDP in the starter diet could be a beneficial nutritional strategy to improve the health and production of broilers provided feeding strategies using various nutrient densities. [ABSTRACT FROM AUTHOR]

Summary Objectives Methods Results Conclusion To assess the predictive potential of the in utero exposome in relation to childhood adiposity as indicated by body mass index z‐scores (BMIz) and the fourth versus first quartile of % fat mass (FM) at median age of 4.6 years.We leveraged data on clinical risk factors for childhood obesity during the perinatal period, along with cord blood per/polyfluoroalkyl substances (PFAS) and cord blood DNA methylation, in 268 mother–offspring pairs. We used the sparsity ranked LASSO penalized regression framework for each outcome and assessed model performance based on % variability explained for BMIz and area under the receiver operating characteristic curve (AUC) for the fourth versus first quartile of %FM. We employed cross‐validation for model tuning and split‐sample validation for model evaluation.Mean ± SD BMIz was 0.01 ± 1.1, %FM was 19.8 ± 6.34%. The optimal model for predicting BMIz explained 19.1% of the variability in the validation set and included only clinical characteristics: maternal pre‐pregnancy BMI, paternal BMI, gestational weight gain, physical activity during pregnancy and child race/ethnicity. The optimal model for fourth versus first quartiles of %FM achieved an AUC of 0.82 ± 0.01 in the validation set, with the clinical features again emerging as the strongest predictors.In this study sample, perinatal chemical exposures and the epigenome have low utility in predicting childhood adiposity, beyond known clinical risk factors. [ABSTRACT FROM AUTHOR]

Objective Methods Results Significance In adult anti‐N‐methyl‐d‐aspartate receptor (NMDAR) encephalitis, corticosteroids are commonly used as first‐line treatment. However, the optimal oral prednisone tapering (OPT) following intravenous methylprednisolone pulse therapy remains unclear. We aim to compare the efficacy and safety of different OPT courses in anti‐NMDAR encephalitis.The CHASE study, a multicenter prospective observational cohort study, enrolled patients with autoimmune encephalitis from October 2011 to March 2023. Patients were grouped based on oral prednisone tapering course: ≤3 months (Group ≤3 month), 3–6 months (Group 3–6 months, including 3 months), and >6 months (Group > 6 months). Kaplan–Meier plots were used to analyze time to relapse and time to total recovery within 2 years.Among 666 screened patients, 171 (median [IQR] age 27 [21.0–36.5] years, 55.0% female) met selection criteria. Responders at 3 months were prevalent in Group ≤3 months (OR 7.251 [95% CI 2.252 to 23.344] and Group 3–6 months (OR, 3.857 [95% CI 1.107 to 13.440] than in Group >6 months. Clinical Assessment Scale for Autoimmune Encephalitis (CASE) scores at 12 months were higher in Group >6 months than in Group ≤3 months and Group 3–6 months (β, −2.329 [95% CI −3.784 to −.875]; β, −2.871 [95% CI −4.490, −1.253]). CASE seizures subscore was higher in Group >6 months than in Group 3–6 months (β, −.452 [95% CI −.788 to −.116]). No significant difference in seizure freedom rates among the groups. Adverse events were higher in Group 3–6 months and Group >6 months than in Group ≤3 months (OR 6.045 [95% CI 2.352 to 15.538]; OR 6.782 [95% CI 1.911 to 24.073]).Longer oral prednisone courses for adult patients with anti‐NMDAR encephalitis did not show superior effects compared to shorter courses in improving modified Rankin Scale (mRS) scores and CASE scores, reducing the risk of relapse within 2 years, or achieving seizure freedom. Instead, extended prednisone courses may lead to more side effects— particularly weight gain. This outcome recommends evaluating the possibility of shortening the duration of oral prednisone after a thorough patient assessment. [ABSTRACT FROM AUTHOR]

RESEARCH HIGHLIGHTSThe use of copper nanoparticles (CuNP) in the diet of broiler chickens has been studied as a potential alternative to antibiotic growth promoters. This study aimed to analyse the antimicrobial properties of CuNP in the feed and water of broiler chickens against Salmonella Enteritidis and to assess the intestinal integrity and toxicity of CuNP supplementation in their diet. The antimicrobial activity of CuNP against S. Enteritidis was tested in microplates to evaluate three water samples with different mineral compositions and in an in vitro digestibility model that simulated the three primary intestinal compartments of birds to assess feed samples. To evaluate in vivo intestinal integrity and toxicity, the birds were divided into four groups (30 birds per group): (1) basal diet (control); (2) basal diet + CuNP (100 ppm); (3) basal diet + enramycin (10 ppm); and (4) basal diet + CuNP (100 ppm) + enramycin (10 ppm). Intestinal samples were collected for histomorphometric evaluation and lactic acid bacteria count, while chest muscle and whole blood samples were collected to determine copper content. A significant reduction in the S. Enteritidis count was observed in both in vitro treatments (water and feed) with CuNP inclusion, compared to the control group. No significant differences in histomorphometric measurements, weight gain, or total lactic acid bacterial counts were found compared to those in the control. These results demonstrate the effectiveness of CuNP in reducing the occurrence of S. Enteritidis and their non-interference with the intestinal integrity of broiler chickens, highlighting the potential of CuNP as an alternative antimicrobial agent in the poultry production chain.Supplementation with CuNP in feed and water reduced Salmonella Enteritidis count.Supplementation with CuNP did not affect intestinal integrity of broilers.CuNP did not affect weight gain or total lactic acid bacterial counts.The results demonstrate the potential of CuNP as alternative antimicrobials.Supplementation with CuNP in feed and water reduced Salmonella Enteritidis count.Supplementation with CuNP did not affect intestinal integrity of broilers.CuNP did not affect weight gain or total lactic acid bacterial counts.The results demonstrate the potential of CuNP as alternative antimicrobials. [ABSTRACT FROM AUTHOR]

1. The objective of this study was to test the effect of microbial phytase and calcium (Ca) levels on the Zn bioavailability depending on the Zn source.2. A total of 144, one-day-old broilers received a diet containing 40 mg Zn/kg for 1 week. They were then assigned to one of the eight experimental treatments during 2 weeks. Diets contained 27 mg native Zn and were formulated according to a 2 × 2 × 2 factorial design with two added Zn sources (23 mg Zn/kg), sulphate (ZnSO4) or oxide (ZnO); two dietary Ca levels of either 6 (low) or 10 g/kg (moderate); and two microbial phytase levels, of either 0 or 750 phytase unit/kg.3. Moderate Ca plus phytase improved body weight gain (BWG) and low Ca level without microbial phytase decreased tibia weight (Ca × Phy; p = 0.049). Zinc oxide resulted in a higher tibia development (i.e. tibia weight and length; p < 0.05) and BWG (p = 0.009) and lower FCR (p < 0.001) compared to ZnSO4.4. Phytase improved tibia Zn concentration especially in birds given ZnSO4 compared to ZnO (Zn × Phy; p = 0.049). Moderate Ca diets improved tibial characteristics and Zn deposition compared to low Ca diets (p < 0.05).5. Soluble Zn in the gizzard increased in the presence of phytase (p = 0.011), while higher dietary Ca reduced this in birds receiving ZnO (p = 0.004). In the jejunum, Zn solubility was higher with phytase (p = 0.008).6. Under the conditions of this study, dietary levels of Ca and microbial phytase affect Zn availability in broilers more than the Zn source. [ABSTRACT FROM AUTHOR]

During parasite infections, the liver may prioritise immune-related pathways over its metabolic functions. Intestinal infections caused by Ascaridia galli and Heterakis gallinarum impair feed intake, nutrient absorption, and weight gain. Histomonas meleagridis, vectored by H. gallinarum, can also damage liver tissues, potentially impairing liver functions. This study examined the hepatic gene expression in three strains of chickens: Ross-308 (R), Lohmann Brown Plus (LB), and Lohmann Dual (LD), 2 weeks after an experimental infection (n = 18) with both A. galli and H. gallinarum or kept as uninfected control (n = 12). Furthermore, H. gallinarum infection led to a co-infection with H. meleagridis. The mixed infections reduced feed intake and the average daily weight gain (P < 0.001). The infections also increased the plasma concentrations of alpha (1)-acid glycoprotein and the antibody titre against H. meleagridis (P = 0.049), with no strain differences (P > 0.05). For host molecular response, 1887 genes were differentially expressed in LD, while 275 and 25 genes were differentially expressed in R and LB, respectively. The up-regulated genes in R and LD were mostly related to inflammatory and adaptive immune responses, while down-regulated genes in LD were involved in metabolic pathways, including gluconeogenesis. Despite performance differences among the strains, worm burdens were similar, but hepatic molecular responses differed significantly. Moreover, there was an indication of a shift in hepatic functions towards immune-related pathways. We, therefore, conclude that the liver shifts its functions from metabolic to immune-related activities in chickens when challenged with mixed parasite species. [ABSTRACT FROM AUTHOR]

Every-other-day fasting (EODF) is a form of caloric restriction that alternates between periods of normal eating and fasting, aimed at preventing and treating diseases. This approach has gained widespread usage in basic research on neurological conditions, including spinal cord injury, and has demonstrated significant neuroprotective effects. Additionally, EODF is noted for its safety and feasibility, suggesting broad potential for application. This study aims to evaluate the therapeutic effects of EODF on spinal cord injury and to investigate and enhance its underlying mechanisms. Initially, the SCI rat model was utilized to evaluate the effects of EODF on pathological injury and motor function. Subsequently, considering the enhancement of metabolism through EODF, bile acid metabolism in SCI rats was analyzed using liquid chromatography-mass spectrometry (LC-MS), and the expression of the bile acid receptor TGR5 was further assessed. Ultimately, it was confirmed that EODF influences the activation of microglia and NLRP3 inflammasomes associated with the TGR5 signaling, along with the expression of downstream pyroptosis pathway related proteins and inflammatory cytokines, as evidenced by the activation of the NLRP3/Caspase-1/GSDMD pyroptosis pathway in SCI rats. The results demonstrated that EODF significantly enhanced the recovery of motor function and reduced pathological damage in SCI rats while controlling weight gain. Notably, EODF promoted the secretion of bile acid metabolites, activated TGR5, and inhibited the NLRP3/Caspase-1/GSDMD pyroptosis pathway and inflammation in these rats. In summary, EODF could mitigate secondary injury after SCI and foster functional recovery by improving metabolism, activating the TGR5 signaling and inhibiting the NLRP3 pyroptosis pathway. [ABSTRACT FROM AUTHOR]

Purpose: Gestational obesity (GO) presents a multifaceted challenge to maternal and fetal health, with an escalating prevalence and far-reaching consequences extending beyond pregnancy. This perspective statement by the Italian Society of Obesity (SIO) provides current insights into the diagnosis, maternal and fetal impacts, and treatment strategies for managing this pressing condition. Methods: This article provides a comprehensive review of the maternal and fetal effects of GO and provides suggestions on strategies for management. Comprehensive review was carried out using the MEDLINE/PubMed, CINAHL, EMBASE, and Cochrane Library databases. Results: The diagnosis of GO primarily relies on pre-pregnancy body mass index (BMI), although standardized criteria remain contentious. Anthropometric measures and body composition assessments offer valuable insights into the metabolic implications of GO. Women with GO are predisposed to several health complications, which are attributed to mechanisms such as inflammation and insulin resistance. Offspring of women with GO face heightened risks of perinatal complications and long-term metabolic disorders, indicating intergenerational transmission of obesity-related effects. While nutritional interventions are a cornerstone of management, their efficacy in mitigating complications warrants further investigation. Additionally, while pharmacological interventions have been explored in other contexts, evidence on their safety and efficacy specifically for GO remains lacking, necessitating further investigation. Conclusion: GO significantly impacts maternal and fetal health, contributing to both immediate and long-term complications. Effective management requires a multifaceted approach, including precise diagnostic criteria, personalized nutritional interventions, and potential pharmacological treatments. These findings underscore the need for individualized care strategies and further research to optimize outcomes for mothers and their offspring are needed. Enhanced understanding and management of GO can help mitigate its intergenerational effects, improving public health outcomes. Level of evidence: Level V narrative review. [ABSTRACT FROM AUTHOR]

AbstractAimMethodsMain ResultsConclusionThis study examined the effects of hyperthermic therapy (HT) on mice fed normal chow or a high-fat diet (HFD) for 18 or 22 weeks, undergoing four or eight weekly HT sessions.Mice were housed within their thermoneutral zone (TNZ) to simulate a physiological response. HFD-induced obesity-related changes, including weight gain, visceral fat accumulation, muscle loss (indicative of obesity sarcopenia), glucose intolerance, and hepatic triglyceride buildup.HT upregulated HSP70 expression in muscles, mitigated weight gain, normalised QUICK index, and reduced plasma HSP70 concentrations. It also lowered the H-index of HSP70 balance, indicating improved immunoinflammatory status, and decreased activated caspase-1 and proliferative senescence in adipose tissue, both linked to insulin resistance.The findings suggest that even animals on a “control” diet but with insufficient physical activity and within their TNZ may experience impaired glycaemic homeostasis. [ABSTRACT FROM AUTHOR]

The effects of nanoscale synthetic zeolite powder (NZeP) levels in diet on water quality, growth performance, muscle proximate composition, and some blood biochemical indices of Nile tilapia (Oreochromis niloticus) fingerlings were evaluated in a 60‐day experiment. One hundred eighty fish with an average weight of 5.91 ± 0.45 g were distributed in three different groups of control (basal diet without NZeP), NZP0.5% (basal diet + 0.5% NZeP), and NZeP1% (basal diet + 1% NZeP) with triplicate. The zeolite particles were characterized via field emission scanning electron microscopy coupled with X‐ray energy dispersive spectroscopy (FE‐SEM/EDS), dynamic light scattering (DLS), and X‐ray diffraction (XRD) techniques. The results revealed that the total ammonia nitrogen (TAN) concentration in the NZeP dietary groups decreased compared to the control group after the 20th day of the experiment (p < 0.05). The TAN concentration in the NZeP1% group was lower than in the NZeP0.5% group on days 50 and 60 (p < 0.05). The final weight, weight gain, and average daily gain parameters were lower in the fish fed on NZeP1%‐supplemented diet than in other dietary groups (p < 0.05). The feed conversion ratio value decreased in the NZeP dietary groups compared to the control (p < 0.05). The lowest FCR value was recorded in the NZeP1% dietary group (p < 0.05). The muscle crude protein content increased in the fish fed on diet supplemented with NZeP1% in comparison to the control (p < 0.05). The aspartate aminotransferase (AST) concentration decreased in the plasma of fish fed on NZeP‐supplemented diets compared to the control (p < 0.05). The plasma glucose concentration was lower in the NZeP1% dietary group than the control (p < 0.05). In conclusion, the adding nanozeolite powder at a level of 1% to diet had positive effects on water quality, the growth performance, and muscle proximate composition of Nile tilapia fingerlings. [ABSTRACT FROM AUTHOR]

ABSTRACT Plant‐based diets (PBD) have been reported throughout history, but are increasingly common in current times, likely in part due to considerable emphasis on climate change and human health and wellness. Many dietary organisations around the world endorse well‐planned, nutritionally adequate PBD, which exclude some or all forms of animal‐based foods. However, special attention must be given to patients who follow PBD and also have food allergy (FA), as avoidance may increase the risk of developing nutritional deficiencies, including poor growth in children, weight loss in adults and vitamin and mineral deficiencies. Given the increasing prevalence of both PBD and food allergen avoidance diets, healthcare providers are likely to counsel patients with FA who also follow a PBD. In this review, an overview of PBD in patients with FA is provided, including recent trends, macro‐ and micronutrient needs, and growth for children and weight gain considerations for adults. With regard to a PBD, special attention should be given to ensure adequate fat and protein intake and improving the bioavailability of several minerals such as iron, zinc, iodine, calcium and magnesium, and vitamins such as A, B2, B12 and D. Although the collective data on growth amongst children following a PBD are varied in outcome and may be influenced in part by the type of PBD, growth must be regularly monitored and in adults weight gain assessed as part of any clinical assessment in those people with FA. [ABSTRACT FROM AUTHOR]

Ex situ lung perfusion (ESLP) is used for organ reconditioning, repair, and re-evaluation prior to transplantation. Since valid preclinical animal models are required for translationally relevant studies, we developed a 17 mL low-volume ESLP for double- and single-lung application that enables cost-effective optimal compliance “reduction” of the 3R principles of animal research. In single-lung mode, ten Fischer344 and Lewis rat lungs were subjected to ESLP and static cold storage using STEEN or PerfadexPlus. Key perfusion parameters, thermal lung imaging, blood gas analysis (BGA), colloid oncotic pressure (COP), lung weight gain, histological work-up, and cytokine analysis were performed. Significant differences between perfusion solutions but not between the rat strains were detected. Most relevant perfusion parameters confirmed valid ESLP with homogeneous lung perfusion, evidenced by uniform lung surface temperature. BGA showed temperature-dependent metabolic activities with differences depending on perfusion solution composition. COP is not decisive for pulmonary oedema and associated weight gain, but possibly rather observed chemokine profile and dextran sensitivity of rats. Histological examination confirmed intact lung architecture without infarcts or hemorrhages due to optimal organ procurement and single-lung application protocol using our in-house-designed ESLP system. [ABSTRACT FROM AUTHOR]

Maintaining a healthy intestinal environment, optimal epithelial barrier integrity, and balanced gut microbiota composition are essential for the growth performance of weaning pigs. We identified Lactiplantibacillus argentoratensis AGMB00912 (LA) in healthy porcine feces as having antimicrobial activity against pathogens and enhanced short-chain fatty acid (SCFA) production. Herein, we assess the protective role of LA using a weaning mouse model with enterotoxigenic Escherichia coli (ETEC) infection. LA treatment improves feed intake and weight gain and alleviates colon shortening. Furthermore, LA inhibits intestinal damage, increases the small intestine villus height compared with the ETEC group, and enhances SCFA production. Using the Kyoto Encyclopedia of Genes and Genomes and other bioinformatic tools, including InterProScan and COGNIZER, we validated the presence of SCFA-producing pathways of LA and Lactiplantibacillus after whole genome sequencing. LA mitigates ETECinduced shifts in the gut microbiota, decreasing the proportion of Escherichia and Enterococcus and increasing SCFA-producing bacteria, including Kineothrix, Lachnoclostridium, Roseuburia, Lacrimispora, Jutongia, and Blautia. Metabolic functional prediction analysis revealed enhanced functions linked to carbohydrate, amino acid, and vitamin biosynthesis, along with decreased functions associated with infectious bacterial diseases compared to the ETEC group. LA mitigates the adverse effects of ETEC infection in weaning mice, enhances growth performance and intestinal integrity, rebalances gut microbiota, and promotes beneficial metabolic functions. These findings validate the functionality of LA in a small animal model, supporting its potential application in improving the health and growth performance of weaning pigs. [ABSTRACT FROM AUTHOR]

The global prevalence of obesity is rising year by year, which has become a public health problem worldwide. Many animal and clinical studies have shown that Lactiplantibacillus plantarum is considered an ideal probiotic and potential supplement for the treatment of obesity. In this study, we aimed to complete the genome sequence of L. plantarum HOM2217, which was isolated from human milk, and study its physiological characteristics and anti-obesity effects in 3T3-L1 cells and rats fed a high-fat diet (HFD) to determine its potential as a starter for functional food products. Whole-genome analysis demonstrated that HOM2217 contained a single circular chromosome of 3,267,529 bp with a GC content of 44.5% and one plasmid (62,350 bp) with a GC content of 38.5%. Compared to the reference strains, HOM2217 demonstrated superior tolerance to gastrointestinal conditions, higher adhesion to intestinal epithelial cell lines, potent antimicrobial activity against Enterobacter cloacae ATCC 13047, and effective cholesterol removal ability in vitro. Treatment with heat-killed HOM2217 significantly reduced lipid accumulation and intracellular triglyceride production in 3T3-L1 adipocytes. Daily treatment of HFD-fed rats with HOM2217 for 7 weeks decreased body weight, body weight gain, and body fat without changes in food intake. HOM2217 also significantly increased the serum high-density lipoprotein cholesterol (HDL-C) level, decreased the serum tumor necrosis factor (TNF-a) and increased short-chain fatty acid (SCFA) (formic acid, acetic acid, and butyric acid) levels in the cecum. Thus, HOM2217 could potentially prevent obesity in rats by inhibiting inflammatory responses and regulating lipid metabolism and SCFAs expression. Therefore, HOM2217 has potential as an alternative treatment for obesity. [ABSTRACT FROM AUTHOR]

Avoidant/restrictive food intake disorder (ARFID) is distinct from other restrictive eating disorders in that body image disturbance or fear of weight gain do not drive restrictive eating. ARFID occurs across the full weight spectrum and youth with ARFID may still experience body weight/shape concerns, not necessarily pathological like body image disturbance is, but research is currently very limited. The current study examined how body weight/shape concerns vary across the full weight spectrum in youth with ARFID. As an exploratory aim, this study also assessed whether body weight/shape concerns differ by ARFID subtypes, age, and gender. Participants included 272 youth between the ages of 8 and 19 presenting for ARFID care at an urban pediatric hospital. Non-parametric Kruskal–Wallis tests were used to examine relations between weight/shape concerns and weight status (i.e. underweight, normal weight, overweight/obesity), ARFID subtypes, age, and gender. Results showed that youth with ARFID and overweight/obesity weight status endorsed greater weight/shape concerns than those with ARFID and normal and underweight statuses (p = .009). Youth who identified as gender identity other than male or female endorsed greater weight/shape concerns than those identifying as cis-male or cis-female (p = .01). However, there were no differences in weight/shape concerns by age or ARFID subtype. These findings demonstrate body weight/shape concerns among youth with ARFID, especially those with overweight/obesity weight status and who are gender diverse. [ABSTRACT FROM AUTHOR]

Background: Gestational diabetes mellitus (GDM) is the most prevalent metabolic disturbance during pregnancy and is associated with adverse outcomes in offspring, including an elevated risk for developing atopic diseases in early childhood. Research is limited regarding only women at risk of GDM among whom some develop GDM while others do not. Information about adverse health outcomes in the offspring of these women is also lacking. The main aim was to assess whether maternal GDM increases the offspring's risk of atopic dermatitis (AD), asthma and allergic rhinitis at 1, 2 and 5 years of age. The second aim was to analyze the association of other maternal health characteristics on the development of these disorders in offspring. Methods: The follow-up study group of the Gestational Diabetes Study (GDS), conducted at Tartu University Hospital, Estonia, between 2014 and 2020, comprised 223 mother–child dyads. All women had at least one risk factor for GDM, of whom only some developed GDM. Information about the diagnoses of interest was obtained from Electronic Health Records. Allergen-specific IgE from children's serum was measured using ImmunoCAP™ Phadiatop™ Infant, with results ≥ 0.35 kU/l considered positive. Statistical analysis was performed using the RStudio software (version 4.3.0). Results: According to our results, only the cases of GDM requiring the use of antidiabetic medications were associated with the development of asthma and/or allergic rhinitis at 2 years of age (aOR 4.68, 95%CI 1.08–20.21, p = 0.039). Maternal obesity (BMI > 30) was associated with offspring´s asthma and/or allergic rhinitis diagnosis at 2 years of age (aOR 3.15, 95%CI 1.03–9.63, p = 0.045). Maternal abnormal weight gain during pregnancy was associated with asthma and/or allergic rhinitis at 5 years of age (aOR 2.76, 95%CI 1.04–7.31, p = 0.041). Conclusion: Among pregnant women at risk for GDM, maternal weight-related factors significantly influence the development of atopic diseases in their children between 1 and 5 years of age, regardless of the GDM diagnosis. This suggests that, besides women with GDM greater attention should also be paid to women at risk but who do not develop GDM, as their children seem to be at higher risk of atopic diseases. [ABSTRACT FROM AUTHOR]

AbstractNaringenin may play a role in browning by increasing thermogenic gene expression. In this study, we encapsulated naringenin using a liposomal formulation and examined the effects of both free and liposomal naringenin on white adipose tissue browning in C57BL6/J mice. In the first phase of the study, naringenin was encapsulated by the liposome method, which is biocompatible and biodegradable. The physical and chemical properties of liposomal naringenin were tested. In the second phase, a total of 48 six-week-old mice were divided into two main groups: prevention and recovery. Each main group was divided into four subgroups: nano-naringenin, void, free-naringenin, and control. The prevention group received a high-fat diet for 10 weeks along with weekly intravenous injections of 20 µM naringenin. On the other hand, the recovery group was first subjected to a high-fat diet for 10 weeks, followed by an additional 10 weeks of the same diet, along with weekly intravenous injections of 20 µM naringenin. Body weight was measured once per week, and brown adipose tissue, inguinal white adipose tissue, and serum samples were collected from each mouse. The mean particle size, polydispersity index and zeta potential values of liposomal naringenin were ∼207 nm, 0.35, and −27 mV, respectively. The encapsulation and loading efficiencies of liposomal naringenin were 94.6 and 19.2%, respectively. Liposomal naringenin exhibited sustained-release behavior, while free naringenin showed a burst-release profile. Liposomal naringenin showed the best physical stability in light and at 4 °C, while free naringenin was more chemically stable in light and at 4 and 22 °C. Free and liposomal naringenin did not significantly reduce weight gain. In the prevention group, liposomal naringenin increased PRDM16 gene expression in inguinal white adipose tissue 4.29 times more than free naringenin (p = 0.010). However, neither formulation significantly altered the expression levels of other browning or adipogenesis markers in the tissues. The results suggest that free naringenin can be efficiently encapsulated in biocompatible and biodegradable nanoparticles. Further research is needed to better understand the physiological effects of liposomal naringenin. [ABSTRACT FROM AUTHOR]

The presence of predators can induce non‐consumptive effects on prey that result in subsequent changes to prey behaviour and defence. We investigate the interaction between top‐down non‐consumptive effects of various stages of the predator Coccinella septempunctata L.(Coleoptera: Coccinellidae) (larvae and adult) and bottom‐up effects of host nutrition on Plutella xylostella (L.) (Lepidoptera: Plutellidae) oviposition and larval host choice. We also compare the effect of presence of intact predators, predators without mandibles, confined predators and a no predator control treatment on P. xylostella larval growth, survival and herbivory. Host plant nutrition influenced the host choice of adult female P. xylostella; no interaction was observed between bottom‐up host plant nutrition and the presence of C. septempunctata adults or larvae on oviposition or larval host choice by P. xylostella. Predator presence impacted larval feeding and weight gain. The presence of free‐moving C. septempunctata adults without mandibles that could not predate P. xylostella reduced mean leaf consumption by P. xylostella larvae to 1.88 ± 0.21 cm2 and reduced weight gain to 2.12 ± 0.16 mg. Despite differences in leaf damage and larval weight gain, survival remained consistent across the non‐consumptive treatments. Intact C. septempunctata larvae reduced leaf damage and subsequent P. xylostella larval weight gain. The presence of larval predators across the non‐consumptive treatments, however, had no effect on feeding damage or weight gain. Results of our investigation indicate that C. septempunctata causes some non‐consumptive effects on P. xylostella that depend on predator life stage, level of confinement and prey life stage. It is likely that P. xylostella responds to multi‐modal cues in predator detection. [ABSTRACT FROM AUTHOR]

BACKGROUND RESULTS CONCLUSION Flaxseed lignans, types of polyphenolic compounds, primarily consist of secoisolariciresinol diglucoside (SDG). Natural plant extracts are becoming increasingly important as feed for ruminant animals. An underutilized plant bioactive component, SDG shows promising benefits for young ruminant production. The objective of this study was to assess the impact of SDG on rumen fermentation using an in vitro rumen simulation technology. Additionally, we tested the effects of SDG (0.20 g kg−1 body weight) on rumen development and production performance of lambs in a production setting.The in vitro addition of 100 mg L−1 SDG demonstrated significant regulatory effects, with a notable decrease in the acetate/propionate ratio (P < 0.05). Feeding trials revealed that SDG significantly increased average daily feed intake and average daily weight gain (P < 0.05), and reduced the acetate/propionate ratio (P < 0.05). This led to a significant increase in the relative abundance of Eubacterium ruminantium (P = 0.038) and Butyrivibrio (P = 0.002). Furthermore, it promoted rumen development and upregulated the relative expression of mRNA of Cyclin E1 and CDK2 in rumen epithelial cells (P < 0.05).The SDG extract optimizes the composition of rumen microbiota and the development of rumen epithelial cells, promoting the growth of pre‐weaning lambs. The SDG additive exhibits potential as a novel growth promoter for ruminant animals, offering a promising solution for sustainable livestock production. © 2024 Society of Chemical Industry. [ABSTRACT FROM AUTHOR]

Simple Summary: There has been an exponential increase in demand for poultry meat and eggs worldwide. Therefore, it is essential to keep coccidiosis under control in broilers to fulfill the increase in demand for protein. The objective of this study was to assess the efficacy of two ionophore coccidiostats against coccidiosis and their impact on broiler gut health and performance. Both the ionophores were effective in treatment against coccidiosis, and out of the two, narasin demonstrated superiority in terms of improved performance parameters compared with salinomycin. This finding is highly important as it significantly focuses on sustainable poultry and, in turn, can help prevent economic losses and maintain broiler health. The objective of this study was primarily to assess the different performance impacts of two ionophore coccidiostats (narasin and salinomycin) used to manage coccidiosis. While both products may be efficacious in controlling disease challenges, previous literature has suggested that some ionophores are less well tolerated by the broiler chickens. In this study, we were particularly interested to know how the use of different coccidiostat programs translates into broiler health and performance, as measured by zootechnical parameters such as the feed conversion ratio, average daily gain, and final body weight. A total of 352 male Ross 308 one-day-old broilers were randomly divided into two treatment groups (T1 and T2). Treatment 1 included a basal diet (BD) + nicarbazin/narasin (Maxiban®, Elanco) at 100 ppm 0–24 days, narasin at 70 ppm 25–42 days, and (2) Treatment 2 included basal diet + nicarbazin/narasin at 100 ppm 0–24 days, salinomycin (Sacox®, Huvepharma) at 70 ppm 25–42 days. Efficacy and performance parameters, slaughter analysis, dry matter (DM) in litter, and intestinal integrity (I2) were measured for the broilers from both treatment groups. The findings demonstrated more favorable results for broilers reared in the group diet fed with narasin (in the finisher phase), including higher daily body weight gain, higher final body weight, lower feed conversion ratio value (improved feed efficiency), and higher European Production Efficiency Factor value, compared with the salinomycin-supplemented group. [ABSTRACT FROM AUTHOR]

Simple Summary: Cold snaps during winter pose a significant challenge for Asian seabass (Lates calcarifer) in Taiwan. Such temperature stress can reduce antioxidant enzyme activity, burdening these enzymes and requiring additional support from non-enzymatic antioxidants. Grape extract (GE), rich in polyphenols, may enhance the antioxidant system in these fish. In a 60-day feeding experiment, various levels of GE (20, 30, and 40 g per kilogram of feed) were tested against a control group to assess their impact on growth, antioxidant-related gene expression, and cold tolerance. The findings demonstrated that the group receiving 20 g of GE per kilogram of feed (GE20) experienced higher improvements in weight gain, antioxidant gene expression, and cold tolerance, suggesting that GE at this concentration could serve as an effective dietary supplement to help Asian seabass withstand the stresses of cold temperatures during cold snaps. Cold snaps during the winter present a critical challenge for Asian seabass (Lates calcarifer) in Taiwan, as sudden temperature drops significantly affect their growth and survival. This study explores the effects of dietary grape extract (GE) from Vitis vinifera on the growth performance, oxidative stress regulation, and thermal tolerance of this commercially valuable fish. Over a 60-day feeding trial, four dietary groups were tested: a control diet without GE and three diets supplemented with GE at 2% (GE20), 3% (GE30), and 4% (GE40) with commercial feed. The results demonstrated that GE supplementation positively influenced growth, with the GE20 group achieving the best weight gain and feed conversion ratio among all groups. The upregulation of the growth-related gene igf-1 in the liver of the GE20 group further supported its superior growth performance. Additionally, GE-fed groups showed increased expression of antioxidant-related genes sod1 and sod2 in the liver, while gpx1 exhibited a significant increase only in the GE20 group, indicating enhanced antioxidant defenses. Cat gene expression remained unchanged, and higher GE doses reduced the expression of gpx1, cat, and igf-1. Furthermore, GE supplementation improved cold tolerance in all treated groups compared to the control. These findings suggest that dietary GE at 20 g/kg is particularly effective in enhancing growth performance and cold tolerance in Asian seabass, offering a promising strategy for boosting fish health and adaptability in aquaculture. [ABSTRACT FROM AUTHOR]

Simple Summary: Wheat bran inclusion beneficially affects the gut health of broilers at low inclusion levels, along with the supplementation of feed additives such as with a stimbiotic It was hypothesized that the coarse or fine particle size of the wheat bran has a significant influence and interaction with stimbiotic on the performance of, and gut-health beneficial effects, in broilers. Coarse- or fine-wheat-bran inclusion or stimbiotic inclusion increased the feed intake and FCR for younger broilers; however, fine wheat bran and stimbiotic inclusion increased the overall weight gain of broilers without influencing their feed intake and FCR. Fine-wheat-bran inclusion increased the jejunum villi height and ileal nutrient digestibility compared to coarse wheat bran or diets without wheat bran in broilers at day 18. Stimbiotic supplementation increased ileal nutrient digestibility at day 42. The particle size of the wheat bran or stimbiotic supplementation had no effects on the cecal total short-chain fatty acid concentration; however, stimbiotic supplementation or wheat bran inclusion tended to decrease the branched-chain fatty acid concentration. Stimbiotic supplementation and inclusion of wheat bran with a reduced particle size into broiler diets have beneficial effects on the overall performance and ileal nutrient digestibility. A 42-day study was conducted with 720-day-old Cobb male broiler chicks allocated to treatments in a 3 × 2 factorial, with the factors as wheat bran (WB) inclusion (no WB, 50 g/kg coarse WB, or 50 g/kg fine WB) and stimbiotic (STB) supplementation in corn-based diets. The inclusion of WB (p < 0.05) or STB supplementation (p < 0.05) increased the FCR and feed intake in the day 0–10 phase. During the day 0–28 phase, coarse-WB inclusion increased (p < 0.05) the FCR, compared to fine WB or diets without WB. In the day 0–42 phase, WB marginally decreased weight gain in diets without STB supplementation, but the STB-supplemented diet, weight gain was greater (p < 0.05) the diet with fine WB compared with diets with coarse WB. Fine-WB inclusion increased the ileal nitrogen and energy digestibility determined at day 18 compared to coarse WB or diets without WB. Supplementation with STB (p < 0.05) or fine WB (p < 0.05) inclusion increased the villi height compared to diets without STB supplementation or coarse WB, or the diet without WB. Coarse or fine WB decreased (p < 0.05) cecal branched-chain fatty acids compared to diets without WB. In conclusion, stimbiotic supplementation to fine WB improved the performance and nutrient digestibility of broilers compared to coarse WB with no effects on the caeca total SCFA concentration. [ABSTRACT FROM AUTHOR]

Simple Summary: Poly-β-hydroxybutyrate (PHB) has proven potential to promote growth and immunity in aquaculture. This study aimed to investigate the effects of adding amorphous Halomonas-PHB to the diet for grouper culture. The findings revealed that supplementation with amorphous Halomonas-PHB did not significantly improve fish growth performance, but it increased the content of fatty acids, including long-chain unsaturated fatty acids C18:1n9, EPA, and DHA in fish muscle. Additionally, it enhanced the resistance of the fish to Vibrio anguillarum possibly by regulating immune-related gene expression in different tissues and organs. These results will contribute valuable insights for the practical application of amorphous Halomonas-PHB in aquaculture. Poly-β-hydroxybutyrate (PHB) is a bacterial metabolite produced by bacteria such as Halomonas sp. that serves as a carbon and energy storage compound for bacteria under nutrient-limited conditions. Two experiments were conducted to investigate the effects of dietary supplementation with Halomonas-PHB on hybrid grouper (Epinephelus fuscoguttatus ♀ × E. lanceolatu ♂). In experiment I, juvenile groupers were fed basal diets supplemented with 3% Halomonas-PHB (3% HM-PHB) containing 1.4% PHB and 3% Halomonas (3% HM) without PHB, as well as a control diet, for seven weeks. The results showed no significant difference in survival rate, weight gain, and crude fat content between the 3% HM-PHB group and the control group; however, the crude protein of the 3% HM-PHB group was significantly lower than that of the control group. Furthermore, supplementation with 3% HM-PHB increased the fatty acids content in fish muscles, including long-chain unsaturated fatty acids C18:1n9, EPA, and DHA. In experiment II, groupers were fed a basal diet supplemented with 6.5% Halomonas-PHB (6.5% HM-PHB) containing 3% PHB and 6.5% Halomonas (6.5% HM) containing no PHB, as well as a basal diet (Control). After seven weeks of rearing, the fish were challenged with Vibrio anguillarum for 48 h. Although no significant difference in survival rate and growth was observed among different groups, the dietary supplement of 6.5% Halomonas-PHB improved the survival rate of V. anguillarum challenged grouper and significantly increased the gene expressions of catalase (CAT) and superoxide dismutase (SOD) in blood, interleukin 1 (IL1) and interleukin 10 (IL10) in the liver, spleen, head kidney, and blood (p < 0.05). In conclusion, dietary supplementation of Halomonas-PHB had no significantly positive effect on fish growth performance but increased the content of fatty acids, including long-chain unsaturated fatty acids C18:1n9, EPA, and DHA in fish muscle; it also improved the V. anguillarum resistance, possibly through increasing immune-related gene expression in different tissues and organs. Our findings offer compelling evidence that Halomonas-PHB can be utilized as a feed additive in intensive grouper farming to enhance the groupers' resistance to Vibrio. [ABSTRACT FROM AUTHOR]

The oxidation of six NbTi-i refractory medium- and high-entropy alloys (NbTi + Ta, NbTi + CrTa, NbTi + AlTa, NbTi + AlMo, NbTi + AlMoTa and NbTi + AlCrMo) were investigated at 1000 °C for 20 h. According to our observation, increased Cr content promoted the formation of protective CrNbO4 and Cr2O3 oxides in NbTi + CrTa and NbTi + AlCrMo, enhancing oxidation resistance. The addition of Al resulted in the formation of AlTi-rich oxide in NbTi + AlTa. Ta addition resulted in the formation of complex oxides (MoTiTa8O25 and TiTaO4) and decreased oxidation resistance. Meanwhile, Mo's low oxygen solubility could be beneficial for oxidation resistance while protective Cr2O3/CrNbO4 layers were formed. In NbTi + Ta, NbTi + AlTa and NbTi + CrTa, a considerable quantity of Ti-rich oxide was observed at the interdendritic region. In NbTi + AlCrMo, the enrichment of Cr and Ti at the interdendritic region could fasten the rate of oxidation. Compared to the recent research, NbTi + AlCrMo alloy is a light-weight oxidation-resistant alloy (weight gain of 1.29 mg/cm2 at 1000 °C for 20 h and low density (7.2 g/cm3)). [ABSTRACT FROM AUTHOR]

This study investigated the effects of ascochlorin (ASC), a natural compound derived from the fungus Ascochyta viciae, on adipogenesis and obesity. We determined the effects of ASC on 3T3-L1 preadipocytes and whether it ameliorated to mitigate high-fat diet (HFD)-induced obesity in C57BL/6J mice. We found that ASC significantly inhibited the differentiation of preadipocytes by modulating the Wnt/β-catenin signaling pathway, a key regulator of adipogenic processes. Treatment with ASC not only reduced the mRNA and protein expression of key adipogenic transcription factors such as C/EBPα and PPARγ, but also reduced lipid accumulation both in vitro and in vivo. In addition, treatment HFD-fed mice with ASC significantly reduced their weight gain and adiposity vs. control mice. These results suggest that ASC has considerable potential as a therapeutic agent for obesity, owing to its dual action of inhibiting adipocyte differentiation and reducing lipid accumulation. Thus, ASC represents a promising candidate as a natural anti-obesity agent. [ABSTRACT FROM AUTHOR]

Obesity is a major global health concern. Studies suggest that the gut microflora may play a role in protecting against obesity. Probiotics, including lactic acid bacteria and Bifidobacterium, have garnered attention for their potential in obesity prevention. However, the effects of Bifidobacterium-fermented products on obesity have not been thoroughly elucidated. Bifidobacterium, which exists in the gut of animals, is known to enhance lipid metabolism. During fermentation, it produces acetic acid, which has been reported to improve glucose tolerance and insulin resistance, and exhibit anti-obesity and anti-diabetic effects. Functional foods have been very popular around the world, and fermented milk is a good candidate for enrichment with probiotics. In this study, we aim to evaluate the beneficial effects of milks fermented with Bifidobacterium strains on energy metabolism and obesity prevention. Three Bifidobacterium strains (Bif-15, Bif-30, and Bif-39), isolated from newborn human feces, were assessed for their acetic acid production and viability in milk. These strains were used to ferment milk. Otsuka–Long–Evans Tokushima Fatty (OLETF) rats administered Bif-15-fermented milk showed significantly lower weight gain compared to those in the water group. The phosphorylation of AMPK was increased and the expression of lipogenic genes was suppressed in the liver of rats given Bif-15-fermented milk. Additionally, gene expression related to respiratory metabolism was significantly increased in the soleus muscle of rats given Bif-15-fermented milk. These findings suggest that milk fermented with the Bifidobacterium strain Bif-15 can improve lipid metabolism and suppress obesity. [ABSTRACT FROM AUTHOR]

Chalcones constitute an important group of natural compounds abundant in fruits and comestible plants. They are a subject of increasing interest because of their biological activities, including anti-diabetic and anti-obesity effects. The simple chalcone structural scaffold can be modified at multiple sites with different chemical moieties. Here, we generated an artificial chalcone, i.e., 3,5-dimethyl-2,4,6-trimethoxychalcone (TriMetChalc), derived from 2′,4′-Dihydroxy-6′-methoxy-3′,5′-dimethylchalcone (DMC). DMC is a major compound of Cleistocalyx operculatus, a plant widely used in Asia for its anti-hyperglycemic activity. Using ob/ob mice as an obesity model, we report that, after 3 weeks of per os administration, TriMetChalc modified food intake through the specific activation of brain structures dedicated to the regulation of energy balance. TriMetChalc also decreased weight gain, glucose intolerance, and hepatic steatosis. Moreover, through extensive liver lipidomic analysis, we identified TriMetChalc-induced modifications that could contribute to improving the liver status of the animals. Hence, TriMetChalc is a chalcone derivative capable of reducing food intake and the addition of glucose intolerance and hepatic steatosis in a mouse model of obesity. In light of these results, we believe that TriMetChalc action deserves to be more deeply evaluated over longer treatment periods and/or in combination with other chalcones with protective effects on the liver. [ABSTRACT FROM AUTHOR]

Context: Annual forage crops provide high-quality fodder for livestock during typical autumn and winter feed-gaps in the south-east of Australia and benefits through rotations in cropping systems. While benefits from intercropping with cereals and pasture or mixing canola and peas have been studied in Australia, the potential animal-production benefits of grazing mixed annual species forage crops have not been examined. Aims: To determine average daily gain (ADG) and rumen fluid parameters when sheep graze mixtures of annual fodder crops compared with a single species. Methods: Ninety six Dorset × Border Leicester × Merino lambs (mean = 44.3 ± 0.55 kg) were allocated to one of the following four treatment groups (n = 24/treatment) on the basis of sex and liveweight; a single species brassica control (canola) (Br) or annual forage species mixes containing brassica (canola, turnip, radish) and cereal (wheat, cereal rye) (B + C), brassica and legume (vetch, arrowleaf clove) (B + L) or brassica, cereal and legume (B + C + L). Liveweight and rumen fluid parameters were assessed prior to grazing and again 21 and 35 days after the commencement of grazing. Key results: Mean ADG from Day 0 to Day 21 was lower for female, but not male, lambs grazing the Br control (231 ± 23 g head−1 day−1) than for those grazing any forage mix (B + C = 292 ± 23 g head−1 day−1, B + L = 296 ± 23 g head−1 day−1, B + C + L = 310 ± 22 g head−1 day−1). Liveweight change over 35 days of grazing was not different between any forage mixtures. Rumen fluid pH was higher (P < 0.001) for sheep grazing forages containing cereals (B + C = 6.97 ± 0.06, B + C + L = 6.86 ± 0.06) than for those grazing brassica or legume (Br = 6.59 ± 0.06, B + L = 6.68 ± 0.06). Total volatile fatty acid concentration was lower and rumen pH was higher when sheep grazed B + C than when they grazed any other forage mix. Conclusions: The higher ADG in females grazing mixtures than in those grazing the Br was related to higher dry matter on offer. Further research should determine whether the lower pH observed when sheep grazed brassica and legume than when grazing mixes containing cereals is associated with subacute rumen acidosis and reduced fibre degradation and forage energy utilisation. Implications: Mixed forage species can provide higher DM on offer and ADG. Improved rumen efficiency could be related to improved growth. Annual forage crops provide high-quality fodder for livestock during autumn and winter feed-gaps in south-eastern Australia. We investigated potential animal-production benefits of grazing mixed annual forage crops. Average daily gain was lower for female, but not male, lambs grazing brassica only than for those grazing forage mixtures. The low rumen pH when lambs grazed brassica only could have been associated with subacute rumen acidosis. Future studies should assess the effect of forage mix on fibre degradation and growth rates over a longer grazing period. [ABSTRACT FROM AUTHOR]

Peptic ulcer disease (PUD) occurs when open sores, or ulcers, form in the stomach or first part of the small intestine caused by bacterial infection (H. pylori) and/or nonsteroidal anti‐inflammatory drug (NSAID) use. This study was conducted to evaluate the antiulcer effect of some plants including genus Symphytum L., and Portulaca oleracea L. on aspirin‐induced acute gastric ulcer in rats. Sixteen male albino rats (200–210 g b.wt. each) were divided into 4 groups, 4 rats each, one of them left as the control −ve group while the other 3 groups orally administered with aspirin at a dose of 200 mg/kg b.wt., for gastric ulcer induction, one of them left as control +ve and the rest 2 groups were orally administered with genus Symphytum L. and Portulaca oleracea L. at a dose of 100 mg/kg b.wt., each. for seven consecutive days. Body weight gain (BWG), the length of gastric ulcer, the volume of gastric juice, the total acidity of gastric juice, and blood sample were assessed. The results showed that orally administered with genus Symphytum L. and Portulaca oleracea L. significantly reduced the length of gastric ulcer, gastric juice volume, and total acidity of gastric juice, in addition to decreasing total cholesterol (TC), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), RBC, WBC, HGB, and PLT. No significant changes were observed in the pH of gastric juice among treated groups. Moreover, in comparison to Portulaca oleracea L., genus Symphytum L. showed preferable results. Accordingly, genus Symphytum L. and Portulaca oleracea L. could be used as plants as curative agents against gastric ulcer in experimental rats. [ABSTRACT FROM AUTHOR]

Objectives Methods Results Conclusions Treatment‐related weight gain and metabolic complications with antiretroviral integrase‐based regimens, especially among Black women, suggest the need for alternative options.We conducted a 48‐week, open‐label, single‐arm, single‐centre, phase IIIb switch study to evaluate the tolerability, safety and efficacy of switching from stable efavirenz‐ or dolutegravir‐based antiretroviral therapy to doravirine/lamivudine/tenofovir disoproxil fumarate in Black women.The 101 participants enrolled (median age 35 years; interquartile range 31–40) were on efavirenz (n = 46; mean duration on therapy 1.7 years) or dolutegravir‐based (n = 55; mean duration 1.5 years) antiretrovirals at screening. Retention at 48 weeks was 92/101 participants, and viral suppression was >90% throughout the study, with a single case of doravirine resistance (106 M, V108I and H221Y mutations). The mean weight percentage change at week 48 was 4.7% (95% confidence interval [CI] 3.0–6.5; p < 0.001), and the adjusted mean change was 2.7 kg (95% CI 1.50–3.98; p < 0.001); for efavirenz, the percentage change was 5.0% (95% CI 2.9–7.1; p < 0.001), and the adjusted weight gain was 3.5 kg (95% CI 1.93–5.13); for dolutegravir, the percentage change was 4.5% (95% CI 1.8–7.3; p < 0.001), and the adjusted weight gain was 2.1 kg (95% CI 0.26–3.90). Statistically significant decreases in lipid panel percent mean to week 48 included: total cholesterol −8.4% (95% CI −11.3 to −5.5; p < 0.001), triglycerides −10.4% (95% CI −16.4 to −4.4; p < 0.001) and high‐density lipoprotein −14.8% (95% CI −18.5 to −11.2%; p < 0.001), with minor differences when disaggregating the mean percent change in lipids between previous efavirenz/dolutegravir regimens. Adverse events due to doravirine were few and mild.Our findings suggest that a switch to doravirine from efavirenz or dolutegravir is safe and effective in Black women, with significant improvement in lipid profiles, but does not arrest progressive weight gain. [ABSTRACT FROM AUTHOR]

Background Method Results Conclusion Nonadherence/discontinuation of antipsychotic (AP) medications represents an important clinical issue in patients across psychiatric disorders, including schizophrenia spectrum disorders (SSDs). While antipsychotic‐induced weight gain (AIWG) is a reported contributor to nonadherence, a systematic review of the association between AIWG and medication nonadherence/discontinuation has not been explored previously.A systematic search was conducted in MEDLINE, EMBASE, PsychINFO, CINAHL, and CENTRAL databases, among others, to help identify all studies which explored adherence, study dropouts, AP switching and/or discontinuations attributable to AIWG among individuals with severe mental illness. A meta‐analysis was also completed where applicable.We identified two categories of studies for the meta‐analysis. Category 1 included three studies, which compared measures of AP adherence or discontinuation across BMI classes/degrees of self‐reported weight gain. When compared to normal weight individuals receiving APs or those who did not report AIWG, individuals who were either overweight or obese or reported weight gain in relation to AP use had an increased odds of AP nonadherence (OR 2.37; 95% CI 1.51–3.73; p = 0.0002). Category 2 had 14 studies which compared measures of discontinuation related to weight gain reported as an adverse effect across different APs. Olanzapine was associated with a 3.32 times (95% CI 2.32–4.74; p < 0.00001) increased likelihood of nonadherence or discontinuation when compared to other APs with lower weight gain liabilities. Similarly, APs with moderate weight gain liability (paliperidone, risperidone, and quetiapine) increased the odds of nonadherence or discontinuation by 2.25 (95% CI 1.31–3.87; p = 0.003) when compared to APs considered to have lower weight gain liability (i.e. haloperidol and aripiprazole). The qualitative summary also confirmed these findings.This review and meta‐analysis suggests that AIWG influences medication nonadherence/discontinuation, whereby APs with higher weight gain liability are associated with nonadherence/discontinuation. Additional studies are needed to confirm these findings. [ABSTRACT FROM AUTHOR]

Ramie fibers have poor flame-retardant properties, which limits their application. To improve the flame-retardant properties of ramie fabric (RF), a durable flame-retardant coating was successfully realized on RF by combining covalent bonding and electrostatic adsorption. Si/P/N flame-retardant coatings were constructed on RF using cationic polyethyleneimine (PEI) and anionic sodium hexametaphosphate (PSP) via the layer-by-layer (LBL) assembly approach with the introduction of 3-glycidoxypropyltrimethoxysilane (GPTMS) as an organic cross-linker. Compared with the untreated RF samples, the fabrics treated with the flame-retardant coating PEI/PSP via the LBL method presented reductions of 51.06%, 48.30%, and 40.05% in the fire growth rate, peak heat release rate, and total heat release, respectively, in the cone calorimeter test. In addition, at a weight gain of 31.57%, the fabric self-extinguished in the UL-94 test within 10 s after leaving the ignition source, resulting in a damaged length of 6.13 cm. G-3 retained the limiting oxygen index (LOI) of 26.40% after 6 laundering cycles (LCs). The TG results revealed that the char residue of G-3 at 800 °C reached 30.34 wt%. The surface of the flame-retardant coating of GPTMS-PEI/PSP had good char formation. This study provides a feasible method for realizing durable flame-retardant RFs. [ABSTRACT FROM AUTHOR]

Obesity is a major public health concern globally. Plant-based ingredients have been proposed as alternative treatments for obesity. L-Theanine (THE), a unique nutraceutical component of tea, is known for its neuroprotective and cognitive benefits. However, there are few reports on THE's effects and mechanisms in improving obesity and its complications. In this study, the alleviating effects and potential mechanisms of THE on obesity-related complications (ORCs) induced by a high-fat diet(HFD) in mice were explored by performing biochemical, hepatic transcriptomics, and plasma metabolomics analyses. The results indicated THE (900 mg/kg of body weight) was effective in mitigating ORCs by decreasing body weight gain and fat deposition, improving glycolipid metabolism disorders, inflammation dysregulation, and alleviating fatty liver formation due to long-term HFD. The hepatic transcriptomics data suggested that THE intervention suppresses the lipid metabolism and inflammation pathways in HFD-fed mice, thereby inhibiting hepatic steatosis and inflammation. Moreover, plasma metabolomics analysis revealed that THE exhibited positive effects on the homeostasis of plasma metabolite balance, such as phosphatidylcholine (PC(14:0/18:1)), phosphatidylethanolamine (Lyso-PE(14:0)), phosphatidic acid (PA(16:0e/18:0)), stigmasterol, and deoxycholic acid glycine conjugate. These metabolites were strongly correlated with ORC-related indicators. Our results indicated that THE, as a functional food additive, possesses potential for ORC alleviation. However, the exact molecular mechanism of how THE alleviates ORCs needs to be investigated in the future. [ABSTRACT FROM AUTHOR]

Solanum lycocarpum St. Hil. is considered a natural anti-inflammatory. In traditional medicine, it is used to reduce cholesterol levels in the treatment of obesity. Foods capable of conferring a protective and nutritious effect have been used to prevent or attenuate the clinical symptoms of inflammatory bowel diseases. Ulcerative colitis is a multifactorial inflammatory bowel disease. This study investigated the impact of the consumption of the fibrous fraction (FF) and resistant starch (RS) of fruta-do-lobo in an experimental model of colitis induced with the use 2,4,6-trinitrobenzene sulphonic acid (TNBS) in rats. The different colitis groups all experienced decreased weight gain, which could be linked to the inflammatory process (p = 0.603). Additionally, the experimental model led to increased oxidative stress, higher levels of pro-inflammatory cytokines, and the elevated gene expression of these cytokines. Despite this, consuming the fibrous fraction of fruta-do-lobo (RS and FF) did not appear to protect the animals against the inflammatory process. Regarding the expression of TNF-α, only the group treated with the drug mesalamine had a reduced serum level of this inflammatory marker (p = 0.03). Our results showed that the diet containing RS and FF did not protect the intestinal mucosa against TNBS inflammation. New studies on the variation in the time of consumption or the supplemented dose of fruta-do-lobo fibers could help to elucidate their effects in protecting the mucosa. [ABSTRACT FROM AUTHOR]

Introduction: As the aquaculture industry intensifies to enhance production efficiency and capacity, the risk of disease outbreaks in high-density systems, such as those for largemouth bass, has escalated. This necessitates the exploration of novel strategies for disease prevention and control. Studies have shown that Atractylodes macrocephala polysaccharide (AMP) possesses the functions of promoting growth and enhancing immune capacity, making it a potential feed additive in animal production. Methods: This study aimed to assess the impact of AMP on the growth performance, serum biochemical indices, and intestinal flora structure of largemouth bass. A total of 360 healthy largemouth bass (mean weight: 15.25 ± 1.29 g) were randomly assigned to four groups, each with three replicates. The groups were fed diets supplemented with 0% (Group D, control group), 0.4% (Group A), 0.8% (Group B), or 1.2% (Group C) AMP for 42 days. Results: The results showed that the addition of an appropriate amount of AMP in the feed significantly improved the weight gain rate (WGR) and specific growth rate (SGR) of largemouth bass, reduced the feed conversion ratio (FCR), and enhanced growth performance. AMP reduced the levels of AST and ALT, indicating a hepatoprotective effect on largemouth bass, with significant differences from the control group (P < 0.05). AMP also improved the intestinal microbiota composition of largemouth bass, positively affecting intestinal health. The analysis of intestinal microbiota revealed 1,288 amplicon sequence variants (ASVs) in the intestine of largemouth bass in Group B, dominated by Firmicutes and Bacteroidota. In contrast, Group C (1.2%) had 920 ASVs, with Fusobacteriota and Firmicutes as the major components, while the relative abundance of Firmicutes was lower, showing significant differences from the control Group D. The functional analysis of intestinal microbiota based on KEGG showed significant differences (P < 0.05) among the four groups in Carbon metabolism, Biosynthesis of amino acids, and Metabolic pathways. Discussion: The study concludes that the inclusion of AMP at 0.8% - 1.2% in the feed can enhance the growth performance and intestinal health of largemouth bass, offering a promising strategy for disease prevention and control in intensive aquaculture settings. [ABSTRACT FROM AUTHOR]

In this study, the toxicity of the trace element zinc (Zn) in Allium cepa L. test material was examined. Toxicity was investigated in terms of physiological, cytogenetic, biochemical, and anatomical aspects. Germination percentage, root length, weight gain, mitotic index (MI), micronucleus (MN) frequency, chromosomal abnormalities (CAs), malondialdehyde (MDA), proline and chlorophyll levels, superoxide dismutase (SOD) and catalase (CAT) enzyme activities, and meristematic cell damage were used as indicators of toxicity. Additionally, the comet test was used to measure the degree of DNA damage. Four groups of A. cepa bulbs—one for control and three for applications—were created. While the bulbs in the treatment groups were germinated with Zn at concentrations of 35, 70, and 140 mg/L, the bulbs in the control group were germinated with tap water. Germination was carried out at room temperature for 72 h and 144 h. When the allotted time was over, the root tips and leaf samples were collected and prepared for spectrophotometric measurements and macroscopic-microscopic examinations. Consequently, Zn treatment led to significant reductions in physiological indicators such as weight gain, root length, and germination percentage. Zn exposure caused genotoxicity by decreasing the MI ratios and increasing the frequency of MN and CAs (p < 0.05). Zn promoted various types of CAs in root tip cells. The most observed of CAs was the sticky chromosome. Depending on the dose, Zn was found to cause an increase in tail lengths in comet analyses, which led to DNA damage. Exposure to Zn led to a significant decrease in chlorophyll levels and an increase in MDA and proline levels. It also promoted significant increases in SOD and CAT enzyme activities up to 70 mg/L dose and statistically significant decreases at 140 mg/L dose. Additionally, Zn exposure caused different types of anatomical damage. The most severe ones are epidermis and cortex cell damage. Besides, it was found that the Zn dose directly relates to all of the increases and decreases in physiological, cytogenetic, biochemical, and anatomical parameters that were seen as a result of Zn exposure. As a result, it has been determined that the Zn element, which is absolutely necessary in trace amounts for the continuation of the metabolic activities of the organisms, can cause toxicity if it reaches excessive levels. [ABSTRACT FROM AUTHOR]

The effect of 3.6 vol% WC addition to ZrB2–20 vol% SiC (ZSW) on oxidation resistance is studied over a broad range of oxidation temperatures, 1000–1800 °C. Non‐WC‐containing samples (ZS) show significant surface damage and degradation during oxidation, losing protective B2O3 and SiO2‐based surface layers and exposing a porous ZrO2 layer and base material for further oxidation. ZSW samples preserve their surface protective layers during oxidation up to 1800 °C while the underlying ZrO2 scale remains dense. The appearance of convection cells on the surface of ZSW samples during oxidation above 1600 °C is reported. This confirms the presence of boron‐rich phases, suppressing oxygen permeation into the material and enhancing oxidation resistance of ZSW samples. During exposure of the samples to 1800 °C for 15 min, ZS and ZSW samples gain 11.1 ± 1.5 and 7.8 ± 0.3 mg cm−2, respectively, due to oxidation. Exposure of the composites for 5 h at 1600 °C results in weight gains of 10.5 and 7.0 mg cm−2 for ZS and ZSW samples, respectively. Cross sections of oxidized samples at 1800 °C show a tight zirconia layer below a glassy surface in ZSW and complete loss of surface glass in ZS, demonstrating the effectiveness of WC addition. [ABSTRACT FROM AUTHOR]

Summary Some periods during the year, such as festive and summer holiday periods, have been associated with weight gain. We aimed to assess the effect of interventions for the prevention of body weight gain during festive and holiday periods in children and adults. A systematic search was conducted in six databases and supplementary sources until January 4, 2023. We included randomized controlled trials (RCTs), cluster‐RCTs, and non‐RCTs. Our primary outcome measure was the change in body weight in adults or the change in BMI z‐score or BMI percentile in children and adolescents. From 4216 records, 12 primary studies (from 22 reports) met the inclusion criteria—10 from the United States, one from the United Kingdom, and one from Chile. Two studies had a low risk of bias, two moderate, seven high, and one critical risk of bias. The meta‐analysis in children included four of seven studies during the summer holidays (six interventions) and showed a mean difference in BMI z‐score favoring the intervention group (−0.06 [95% CI −0.10, −0.01], p = 0.01, I2 = 0%, very low certainty evidence). The meta‐analysis in adults included five studies during festive periods with a mean difference in weight favoring the intervention group (−0.99 kg [95% CI −2.15, 0.18], p = 0.10, I2 = 89%, very low certainty evidence). This review has highlighted potential interventions to prevent the increase in body weight during holiday periods. More work is needed to improve the quality of the evidence and to extend it to countries outside of the United States and United Kingdom and to the adolescent population. [ABSTRACT FROM AUTHOR]

In this paper, we prepared Al2O3–ZrO2–SiB6 composite ceramics with excellent performance by introducing the second‐phase high‐strength healing agent SiB6 in zirconia‐toughened alumina system, artificially created cracks using Vickers hardness tester, investigated the effects of heat treatment temperature (600–1200°C) and time (0–300 min) on the microscopic morphology and bending strength of the ceramics, revealed the healing mechanism, and studied the oxidation resistance properties. It was found that the healing effect was better at heat treatment of 90 min at 700°C and 60 min at 800°C, and the flexural strength was restored to more than 95% of that of the smooth specimens in both cases. Crack repair was mainly achieved by the reaction of SiB6, ZrB2, and B4C with O2. Below 800°C, healing was mainly achieved by the reaction of SiB6 and B4C with O2, and the generated B2O3 and SiO2 migrated toward the crack to repair it. When the healing temperature is higher than 800°C, ZrB2 also reacts with oxygen to produce B2O3 and t‐ZrO2. It was found that the oxidation weight gain per unit area of the Al2O3–ZrO2–SiB6 ceramic composite at different temperatures was small, and it has excellent oxidation resistance. [ABSTRACT FROM AUTHOR]

ABSTRACT In ecological contexts natural selection might favor individuals with a larger body mass to monopolize resources; however, there is wide variation in body mass within populations and potential factors. In this study, we evaluated whether fruit production limits body mass in one group of Sapajus apella, its effects on behavior, and whether there is a relationship between social status and body mass. We recorded activity patterns using focal follows (20 min), body mass (using a modified Ohaus scale), and community wide fruit production estimates (from 60 fruit traps). Body mass remained relatively stable during periods of food scarcity, but in periods of abundance most individuals gained weight, as indicated by their relative growth rates (RGR). Subordinate subadults showed the highest RGR, as expected by their age. In periods of high fruit production activities as traveling, grooming, and playing were more frequent than during fruit scarcity, suggesting energy maximization and potential energetic constraints. We found differences in behavior within the group, as the alpha male was observed feeding more frequently (and for longer periods of time), was more aggressive (e.g., feeding trees), and received more grooming than other individuals. In addition, the alpha male was 60% heavier than the group's average body mass. Our study supports the hypothesis that body weight gain is related to fruit abundance and that body size is associated with social dominance; however, large individuals (both males and females) seem to incur in high metabolic or reproductive costs, as they do not gain much weight as smaller individuals. [ABSTRACT FROM AUTHOR]